Glycerophospholipid (GPL)

Glycerophospholipids are the primary structural components of all biological membranes, organized into a bilayer that provides the essential matrix for cellular life. They consist of a glycerol-3-phosphate backbone esterified with two fatty acids and a polar head group, such as choline, ethanolamine, or serine, which dictates their specific chemical properties and biological roles (Source: NIH, PubChem). Beyond their structural function, they serve as dynamic reservoirs for signaling molecules like arachidonic acid and diacylglycerol, which are critical for inflammatory and growth-related pathways (Source: PubMed). In clinical medicine, these lipids are significant targets for antimicrobial therapy; for instance, daptomycin specifically targets phosphatidylglycerol in Gram-positive bacterial membranes to cause cell death (Source: StatPearls). Additionally, synthetic alkylphospholipids like miltefosine are used to treat cancer and leishmaniasis by disrupting membrane-associated signaling and inducing apoptosis (Source: PMC). Because glycerophospholipids are ubiquitous in human cells, therapeutic strategies must carefully balance efficacy against potential toxicities like hemolysis or organ damage (Source: Wikipedia).

Other names

Membrane glycerol-3-phospholipidsPhosphoglyceridesGlycerol-3-phospholipidsGlycerophosphatidesPhosphoglycerols

Drugs targeting these molecules typically act through membrane permeabilization, pore formation, or the disruption of lipid-mediated signaling pathways. For example, lipopeptide antibiotics bind to specific bacterial phospholipids to induce rapid depolarization, while synthetic phospholipid analogs interfere with CTP:phosphocholine cytidylyltransferase to inhibit cell survival signaling.